503859-17-4

Usage

Uses

Used in Pharmaceutical Industry:
Tert-butyl 4-bromo-3-(bromomethyl)benzoate is used as a reagent in organic synthesis for the production of various pharmaceutical compounds. Its unique structure allows it to be a valuable building block in the development of new drugs.
Used in Agrochemical Industry:
tert-butyl 4-bromo-3-(bromomethyl)benzoate is also used in the field of agrochemicals, where it serves as a reagent in the synthesis of various agrochemical products.
Used in Organic Chemistry:
Tert-butyl 4-bromo-3-(bromomethyl)benzoate is used as a reagent for the preparation of esters and ethers, which are important in the synthesis of a wide range of organic compounds.
Used as a Protecting Group:
In organic chemistry reactions, tert-butyl 4-bromo-3-(bromomethyl)benzoate is utilized as a protecting group to temporarily mask functional groups, allowing for selective reactions to occur. This feature is crucial in complex organic synthesis processes.

Upstream product

• 347174-28-1 tert-butyl 4-bromo-3-methylbenzoate 
• 21900-25-4 4-bromo-3-methylbenzoyl chloride 
• 7697-28-1 4-bromo-3-methylbenzoic acid 

Downstream Products

• 1310458-88-8 C₃₆H₃₆N₄O₄ 
• 1310458-89-9 (E)-3-(2-(4-((4'-cyano-4-(4-hydroxypiperidine-1-carbonyl)biphenyl-2-yl)methoxy)phenyl)-1-cyclohexyl-1H-imidazol-4-yl)-2-methylacrylic acid 
• 1310458-90-2 C₃₄H₃₅N₃O₅S 
• 1310458-91-3 C₃₅H₃₇N₃O₅S 
• 1310458-92-4 C₃₇H₃₉N₃O₆S 
• 1310458-95-7 C₄₀H₄₃BrClN₃O₅ 
• 1310458-83-3 C₃₅H₃₆ClN₃O₄ 
• 1310458-84-4 C₃₈H₄₀ClN₃O₅ 
• 1310458-99-1 C₃₇H₄₀ClN₃O₄ 
• 1310458-96-8 C₄₀H₄₄ClN₃O₅ 
• 1310458-97-9 C₃₇H₄₀ClN₃O₅ 
• 1310458-98-0 C₃₇H₃₈N₄O₄ 
• 1310459-00-7 C₃₈H₄₀N₄O₄ 
• 1310459-01-8 C₄₁H₄₄N₄O₅ 

Relevant academic research and scientific papers

The Synthesis and evaluation of a novel class of (E)-3-(1-cyclohexyl-1H- pyrazol-3-yl)-2-methylacrylic acid Hepatitis C virus polymerase NS5B inhibitors

Herein we report the identification and evaluation of a novel series of (E)-3-(1-cyclohexyl-1H-pyrazol-3-yl)-2-methylacrylic acid derivatives identified from a deannulation study performed on the reported benzimidazole NS5B inhibitor, 1. This resulted in

Development of an Si-rhodamine-based far-red to near-infrared fluorescence probe selective for hypochlorous acid and its applications for biological imaging

A far-red to near-infrared (NIR) fluorescence probe, MMSiR, based on Si-rhodamine, was designed and synthesized for sensitive and selective detection of HOCl in real time. MMSiR and its oxidized product SMSiR have excellent properties, including pH-indepe

Benzimidazole derivatives bearing substituted biphenyls as hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors: Structure-activity relationship studies and identification of a potent and highly selective inhibitor JTK-109

Following the discovery of a new series of benzimidazole derivatives bearing a diarylmethyl group as inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase (HCV NS5B RdRp), we extended the structure-activity relationship (SAR) study to analogue

NITROGEN-CONTAINING HETEROARYL DERIVATIVES

Disclosed are compounds, compositions and methods for treating Flaviviridae family virus infections.